Icad Inc Reports Results For The Quarter Ended September 30: Earnings Summary

icad

14/11/2024 04:04

* ICAD Inc  ICAD.OQ  reported a quarterly adjusted loss of 7
cents​​ per share for the quarter ended September 30, lower than
the same quarter last year, when the company reported EPS of -5
cents.  The mean expectation of three analysts for the quarter
was for a loss of 8 cents per share. Wall Street expected
results to range from -9 cents to -8 cents per share.
    * Revenue rose 3.5% to $4.22 million from a year ago;
analysts
expected $4.52 million. 
    * ICAD Inc's reported EPS for the quarter was a loss of 7
cents​.
    * The company reported a quarterly loss of $1.8 million.
    * ICAD Inc shares had risen by 53.4% this quarter and
gained 35.6%
so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the advanced
medical
equipment & technology peer group is also "buy"

Wall Street's median 12-month price target for ICAD Inc is 3.00 
This summary was machine generated from LSEG data November 14 at
04:03 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.08          -0.07          Beat
 Jun. 30 2024      -0.07          -0.06          Beat
 Mar. 31 2024      -0.06          -0.05          Beat
 Dec. 31 2023      -0.05          0.05           Beat